KROS
Keros Therapeutics Inc
11.40$
+0.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.08 | 5.15 | 0.45 | 0.35 | 0.01 | 0.02 | 0.92 | 1.68 | |
| 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | – | – | |
| -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 5.15 | 0.44 | 0.34 | 0.01 | 0.00 | – | – | |
| 1.15 | 1.24 | 1.30 | 1.12 | 1.36 | 1.13 | 1.19 | 1.07 | 0.48 | 0.66 | 0.82 | 1.13 | 3.83 | |
| 0.31 | 0.30 | 0.35 | 0.28 | 0.27 | 0.26 | 0.26 | 0.36 | 0.25 | 0.43 | 0.52 | 0.43 | 2.05 | |
| 1.44 | 1.55 | 1.65 | 1.40 | 1.63 | 1.39 | 1.44 | 1.42 | 0.72 | 1.09 | 1.32 | 1.56 | 5.84 | |
| -1.46 | -1.54 | -1.65 | -1.40 | -1.62 | -1.32 | 3.71 | -0.98 | -0.38 | -1.08 | -1.32 | -1.56 | -5.12 | |
| 0.00 | 0.00 | – | – | – | – | – | – | – | – | – | – | – | |
| -1.33 | -1.34 | -1.46 | -1.25 | -1.47 | -1.13 | 3.86 | -0.81 | -0.21 | -0.92 | -1.21 | -1.45 | -4.35 | |
| -0.01 | 0.13 | -0.01 | – | – | 0.01 | 0.24 | -0.05 | -0.04 | -0.06 | – | 0.11 | – | |
| -1.33 | -1.34 | -1.46 | -1.25 | -1.47 | -1.14 | 3.62 | -0.76 | -0.18 | -0.86 | -1.21 | -1.45 | -4.20 | |
| -1.31 | -1.33 | -1.45 | -1.25 | -1.46 | -0.72 | 3.87 | -0.80 | -0.20 | -0.90 | -1.19 | -1.43 | -4.27 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.